<p>(<b>A</b>) When animals were immunized twice with bmDCs loaded with CD11c-scFv-IDRgag or control-scFv-IDRgag in one week interval and challenged one week after the second immunization, animals immunized with bmDCs loaded with CD11c-scFv-IDRgag were protected significantly better against FV induced splenomegaly, which correlated with a significantly lower frequency of infected cells in the spleen (<b>B</b>). Data were analyzed by one-way ANOVA with Tukey’s multiple comparison test. Significance was labeled with * if p<0.05, ** if p<0.01, *** if p<0.001. Data represents results from one experiment.</p
<p>Lethally irradiated C57BL/6 mice that had been reconstituted with wild-type (WT) or CD11c-DTR bon...
<p>(<b>A</b>) Activation induced by DCs loaded with 10 µg/ml of CD11c-scFv-IDRgag was equivalent wit...
a<p>Mice were nasally immunized weekly for three consecutive weeks with OVA plus Ad-FL.</p><p>One we...
<p>(<b>A and B</b>) By gating on CD43/CD44 double positive effector CD8<sup>+</sup> T cell populatio...
<p>(<b>A</b>) CD8 TCRtg B6 mice injected with CD11c-scFv-IDRgag-treated bmDCs showed a significant h...
<p>CB6F1 mice were immunized twice with Ad.pIXgp70 in combination with adenoviral vectors encoding s...
<p>C57BL/6 mice (each group, n = 10) were immunized i.p with CMT.64 cells (5×10<sup>6</sup> cells/mo...
<p>Mice were nasally immunized weekly for three consecutive weeks with OVA plus Ad-FL. (A) One week ...
<p>(<b>A</b>) To study proliferation of FV-specific CD8<sup>+</sup> T cells induced by CD11c-scFv-ID...
A. Timeline for mice immunization with EDIII-Fc and blood collection. Balb/c mice were immunized wit...
IFNAR-/- mice aged 4–6 weeks old were immunized twice, two weeks apart with pVax1 or scMAYV-E using ...
IFNAR-/- mice aged 4–6 weeks were immunized twice with 25 μg of scMAYV-E two weeks apart using EP-en...
<p>B6 mice were i.v. immunized with 10<sup>6</sup> pfu of the indicated viral vectors or left untrea...
<p>BALB/c mice were infected with 10 IMLD<sub>50</sub> DRV and treated at 0 (A) or 4 (B) dpi with me...
<p>CB6F1 mice were prime- and boost-immunized with Ad.pIXgp70 in combination with interleukin-encodi...
<p>Lethally irradiated C57BL/6 mice that had been reconstituted with wild-type (WT) or CD11c-DTR bon...
<p>(<b>A</b>) Activation induced by DCs loaded with 10 µg/ml of CD11c-scFv-IDRgag was equivalent wit...
a<p>Mice were nasally immunized weekly for three consecutive weeks with OVA plus Ad-FL.</p><p>One we...
<p>(<b>A and B</b>) By gating on CD43/CD44 double positive effector CD8<sup>+</sup> T cell populatio...
<p>(<b>A</b>) CD8 TCRtg B6 mice injected with CD11c-scFv-IDRgag-treated bmDCs showed a significant h...
<p>CB6F1 mice were immunized twice with Ad.pIXgp70 in combination with adenoviral vectors encoding s...
<p>C57BL/6 mice (each group, n = 10) were immunized i.p with CMT.64 cells (5×10<sup>6</sup> cells/mo...
<p>Mice were nasally immunized weekly for three consecutive weeks with OVA plus Ad-FL. (A) One week ...
<p>(<b>A</b>) To study proliferation of FV-specific CD8<sup>+</sup> T cells induced by CD11c-scFv-ID...
A. Timeline for mice immunization with EDIII-Fc and blood collection. Balb/c mice were immunized wit...
IFNAR-/- mice aged 4–6 weeks old were immunized twice, two weeks apart with pVax1 or scMAYV-E using ...
IFNAR-/- mice aged 4–6 weeks were immunized twice with 25 μg of scMAYV-E two weeks apart using EP-en...
<p>B6 mice were i.v. immunized with 10<sup>6</sup> pfu of the indicated viral vectors or left untrea...
<p>BALB/c mice were infected with 10 IMLD<sub>50</sub> DRV and treated at 0 (A) or 4 (B) dpi with me...
<p>CB6F1 mice were prime- and boost-immunized with Ad.pIXgp70 in combination with interleukin-encodi...
<p>Lethally irradiated C57BL/6 mice that had been reconstituted with wild-type (WT) or CD11c-DTR bon...
<p>(<b>A</b>) Activation induced by DCs loaded with 10 µg/ml of CD11c-scFv-IDRgag was equivalent wit...
a<p>Mice were nasally immunized weekly for three consecutive weeks with OVA plus Ad-FL.</p><p>One we...